Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection

Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance

(2014) Chung-Su Park et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of TailoredHelicobacter pyloriEradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion

(2014) Mitsushige Sugimoto et al.   HELICOBACTER

Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance

(2013) H. J. Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations

(2012) C. Y. Tay et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection

(2012) Giulia Fiorini et al.   Clinical Gastroenterology and Hepatology

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori

(2012) A. Cosme et al.   CLINICAL MICROBIOLOGY AND INFECTION

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Eradication of Helicobacter pylori in Children in Vietnam in Relation to Antibiotic Resistance

(2012) Thi Viet Ha Nguyen et al.   HELICOBACTER

Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains

(2012) Javier Molina-Infante et al.   HELICOBACTER

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan

(2012) Yoshihiro Hirata et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial

(2012) J.-M. Liou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dual therapy for third-lineHelicobacter pylorieradication and urea breath test prediction

(2012) Toshihiro Nishizawa   WORLD JOURNAL OF GASTROENTEROLOGY

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-

(2010) Yuan Wenzhen et al.   INTERNAL MEDICINE

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Tailored eradication therapy based on fecalHelicobacter pyloriclarithromycin sensitivities

(2008) Takashi Kawai et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Gatifloxacin-based triple therapy as a third-line regimen forHelicobacter pylorieradication

(2008) Toshihiro Nishizawa et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY